ChemLifeIntel
Access

Bow & Arrow, Dietary Supplement, Libido Enhancer for Men

TRACKED

CASHSN
THERAPEUTIC AREAS
MOLECULE INTELLIGENCE SNAPSHOTlive
14
Manufacturers monitored
38
Intelligence briefs
3
Active regulatory actions
₹2,800 Cr
Est. India export value

INTELLIGENCE

Showing 1 of 1 briefs for Bow & Arrow, Dietary Supplement, Libido Enhancer for Men
REGULATORY INTELLIGENCE·Product Recall

FDA Class I Recall: Med Man Distribution's Bow & Arrow Supplement Contained Undeclared Sildenafil

Med Man Distribution, Inc. initiated a Class I recall of its Bow & Arrow dietary supplement due to undeclared sildenafil, identified by FDA analysis. This event, terminated on October 17, 2023, underscores critical regulatory and supply chain risks for companies distributing products without proper drug approvals, impacting nationwide US markets and demanding enhanced due diligence.

90-Day Activity
MKMeera Krishnan· Senior Regulatory Intelligence Analyst
2020-03-25 Product Recall